Cano Health, Inc. - Feb 5, 2024 Form 4 Insider Report for MSP Recovery, Inc. (LIFW)

Role
10%+ Owner
Signature
Cano Health, Inc., By: /s/ David J. Armstrong, Name: David J. Armstrong, Title: General Counsel
Stock symbol
LIFW
Transactions as of
Feb 5, 2024
Transactions value $
-$164,537
Form type
4
Date filed
2/7/2024, 07:00 PM
Previous filing
Feb 2, 2024
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFW Class A Common Stock Sale -$49.1K -53.4K -0.95% $0.92 5.54M Feb 5, 2024 See Footnote F1, F2
transaction LIFW Class A Common Stock Sale -$54.1K -65.9K -1.19% $0.82 5.47M Feb 6, 2024 See Footnote F2, F3
transaction LIFW Class A Common Stock Sale -$61.4K -80.8K -1.48% $0.76 5.39M Feb 7, 2024 See Footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.88 to $0.9832. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8016 to $0.925. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.